Knight Capital Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Knight Capital Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$602K	Buy	+37,033	New	+$1.15M	0.01%	1526

Other funds holding INFI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Knight Capital Group's INFI Position: Q2 2013 in Review

Knight Capital Group opened a new position in Infinity Pharmaceuticals, Inc. (INFI) in Q2 2013: 37,033 shares worth $602K. The stake represents 0.01% of the portfolio and ranks #1526 among its holdings.

119 funds tracked by Wall St. Rank hold INFI as of Q2 2013.

Knight Capital Group held 37,033 shares of Infinity Pharmaceuticals, Inc. worth $602K as of Q2 2013.
Infinity Pharmaceuticals, Inc. was a new Knight Capital Group position in Q2 2013.
Infinity Pharmaceuticals, Inc. made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #1526 holding.
119 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.